New Method Of Treatment Glaucoma

New Method Of Treatment Glaucoma.
Contact lenses that perform glaucoma medication over elongate periods are getting closer to reality, speak researchers working with laboratory animals. In their study, the lenses delivered the glaucoma soporific latanoprost (brand notability Xalatan) continuously to animals for a month vito. It's hoped that some prime such lenses will put in place of sight drops now in use to treat the eye disease, the researchers said Dec 2013.

And "In general, vision drops are an unskilled method of poison delivery that has notoriously poor patient adherence," mull over lead author Dr Joseph Ciolino, a cornea master at the Massachusetts Eye and Ear Infirmary, said in an sickbay announcement release. "This contact lens destine can potentially be used as a treatment for glaucoma and as a rostrum for other eye drug delivery applications" mechanism. Glaucoma is the outstanding cause of irreversible blindness worldwide.

The lenses, which appeared solid in cell culture and zoological studies, are the first to be shown to release drugs for this hunger in animals, according to the researchers. The study appears online and in the January issue issue of the daily Biomaterials. The lens the research line-up developed "is capable of delivering heavy-set amounts of drug at substantially constant rates over weeks to months," Daniel Kohane, chief of the Laboratory for Biomaterials and Drug Delivery at Boston Children's Hospital, said in the bulletin release formula. Ciolino said a noninvasive procedure of continual eye-drug enunciation could save millions of kinsfolk from blindness if it helps them comply with their medication regimen.